What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- Chemotherapy
His primary areas of investigation include Internal medicine, Head and neck cancer, Surgery, Oncology and Radiation therapy.
His research in Cancer, Chemotherapy, Cetuximab, Carcinoma and Phases of clinical research are components of Internal medicine.
He usually deals with Cetuximab and limits it to topics linked to Survival analysis and Hazard ratio and Nimotuzumab.
His Head and neck cancer study combines topics from a wide range of disciplines, such as Swallowing, Quality of life, Nuclear medicine, Stage and Performance status.
His Surgery research includes themes of Gastroenterology and Epidermoid carcinoma.
His work carried out in the field of Oncology brings together such families of science as Clinical endpoint and Clinical trial.
His most cited work include:
- Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck (3893 citations)
- The BATTLE Trial: Personalizing Therapy for Lung Cancer (668 citations)
- Axitinib Is an Active Treatment for All Histologic Subtypes of Advanced Thyroid Cancer: Results From a Phase II Study (532 citations)
What are the main themes of his work throughout his whole career to date?
Merrill S. Kies mostly deals with Internal medicine, Oncology, Surgery, Chemotherapy and Head and neck cancer.
His Cancer, Phases of clinical research, Induction chemotherapy and Cetuximab study in the realm of Internal medicine connects with subjects such as In patient.
The various areas that Merrill S. Kies examines in his Oncology study include Head and neck squamous-cell carcinoma, Cisplatin, Epidermal growth factor receptor and Head and neck.
The Surgery study combines topics in areas such as Gastroenterology and Carcinoma, Epidermoid carcinoma.
Merrill S. Kies has included themes like Regimen, Concomitant and Toxicity in his Chemotherapy study.
His Head and neck cancer study combines topics in areas such as Quality of life, Swallowing and Clinical trial.
He most often published in these fields:
- Internal medicine (60.68%)
- Oncology (47.37%)
- Surgery (32.51%)
What were the highlights of his more recent work (between 2015-2021)?
- Internal medicine (60.68%)
- Oncology (47.37%)
- Cancer (22.91%)
In recent papers he was focusing on the following fields of study:
Merrill S. Kies focuses on Internal medicine, Oncology, Cancer, Surgery and Radiation therapy.
Merrill S. Kies combines subjects such as Head and neck squamous-cell carcinoma and Cetuximab with his study of Oncology.
Merrill S. Kies works mostly in the field of Cetuximab, limiting it down to topics relating to Carboplatin and, in certain cases, Mucositis.
His study in Cancer is interdisciplinary in nature, drawing from both Larynx and Clinical endpoint.
In his study, Chemoradiotherapy, Gene, MYB, Fusion transcript and Fusion gene is strongly linked to Adenoid cystic carcinoma, which falls under the umbrella field of Surgery.
His Radiation therapy research is multidisciplinary, relying on both Complete blood count, Systemic therapy and Hazard ratio.
Between 2015 and 2021, his most popular works were:
- Combining Immune Checkpoint Blockade and Tumor-Specific Vaccine for Patients With Incurable Human Papillomavirus 16-Related Cancer: A Phase 2 Clinical Trial. (137 citations)
- Novel MYBL1 Gene Rearrangements with Recurrent MYBL1–NFIB Fusions in Salivary Adenoid Cystic Carcinomas Lacking t(6;9) Translocations (96 citations)
- Intensity-modulated proton beam therapy (IMPT) versus intensity-modulated photon therapy (IMRT) for patients with oropharynx cancer – A case matched analysis (89 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Chemotherapy
Merrill S. Kies mainly focuses on Surgery, Internal medicine, Radiation therapy, Oncology and Cancer.
His research related to Phases of clinical research and Chemotherapy might be considered part of Internal medicine.
His study explores the link between Radiation therapy and topics such as Hazard ratio that cross with problems in Head and neck, Merkel cell carcinoma, Neck dissection, Head neck and Adjuvant therapy.
The concepts of his Oncology study are interwoven with issues in Phase i trials and Targeted therapy.
His study in the fields of Locally advanced and Conditional survival under the domain of Cancer overlaps with other disciplines such as Risk model.
Merrill S. Kies focuses mostly in the field of Radiology, narrowing it down to topics relating to Feeding tube and, in certain cases, Head and neck cancer.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
